BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28196208)

  • 1. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
    McDonald R; Ding K; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chan S; Chow E
    JAMA Oncol; 2017 Jul; 3(7):953-959. PubMed ID: 28196208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Am J Hosp Palliat Care; 2018 Apr; 35(4):718-723. PubMed ID: 28950727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
    Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
    Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S185-S194. PubMed ID: 29156903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
    Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
    BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should dexamethasone be standard in the prophylaxis of pain flare after palliative radiotherapy for bone metastases?-a debate.
    Niglas M; Raman S; Rodin D; Detsky J; DeAngelis C; Soliman H; Chow E; Tsao MN
    Ann Palliat Med; 2018 Apr; 7(2):279-283. PubMed ID: 28595438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases.
    Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S248-S256. PubMed ID: 29156910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.
    Chow R; Ding K; Ganesh V; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; van Acht M; Wanders R; Babington S; Demas WF; Wilson CF; Wong RKS; Brundage M; Zhu L; Chow E
    Radiother Oncol; 2018 Mar; 126(3):541-546. PubMed ID: 29102263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases.
    Caissie A; Zeng L; Nguyen J; Zhang L; Jon F; Dennis K; Holden L; Culleton S; Koo K; Tsao M; Barnes E; Danjoux C; Sahgal A; Simmons C; Chow E
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):125-33. PubMed ID: 21917431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.
    Harding D; Giles SL; Brown MRD; Ter Haar GR; van den Bosch M; Bartels LW; Kim YS; Deppe M; deSouza NM
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):233-242. PubMed ID: 29317145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.
    Chow E; Meyer RM; Chen BE; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Nabid A; Tissing-Tan CJ; Oei B; Babington S; Demas WF; Wilson CF; Wong RK; Brundage M
    J Clin Oncol; 2014 Dec; 32(34):3867-73. PubMed ID: 25349296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar R; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Support Care Cancer; 2016 Dec; 24(12):4871-4878. PubMed ID: 27465049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated radiotherapy for complicated bone metastases in patients with poor performance status: a phase II international trial.
    Silva MF; Marta GN; Lisboa FPC; Watte G; Trippa F; Maranzano E; da Motta NW; Popovic M; Ha T; Burmeister B; Chow E
    Tumori; 2019 Apr; 105(2):181-187. PubMed ID: 28665472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for psychological distress before radiotherapy for painful bone metastases may be useful to identify patients with high levels of distress.
    Westhoff PG; de Graeff A; Monninkhof EM; Berveling MJ; van Vulpen M; Leer JWH; Marijnen CAM; Reyners AKL; van der Linden YM;
    Acta Oncol; 2017 Dec; 56(12):1720-1727. PubMed ID: 28893119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for overall quality of life in patients with advanced cancer.
    Cramarossa G; Chow E; Zhang L; Bedard G; Zeng L; Sahgal A; Vassiliou V; Satoh T; Foro P; Ma BB; Chie WC; Chen E; Lam H; Bottomley A
    Support Care Cancer; 2013 Jun; 21(6):1709-16. PubMed ID: 23338229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy.
    Caissie A; Culleton S; Nguyen J; Zhang L; Zeng L; Holden L; Dennis K; Chan E; Jon F; Tsao M; Danjoux C; Sahgal A; Barnes E; Koo K; Chow E
    Support Care Cancer; 2012 Apr; 20(4):841-8. PubMed ID: 21538099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.